Related Experiment Video
Updated: Apr 8, 2026
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
RNA-based next-generation sequencing strategy for screening MDM2-amplified sarcomas
Cheng Lei1,2, Hongjing Zang1,2, Haixia Zhang3
1Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
A new RNA sequencing algorithm accurately screens for dedifferentiated liposarcoma (DDLPS) by analyzing fusion events and MDM2 transcript levels, improving diagnosis of this challenging soft tissue sarcoma.
Area of Science:
- Oncology
- Genomics
- Pathology
Background:
- Accurate diagnosis of soft tissue sarcomas and bone tumors is challenging.
- Targeted RNA next-generation sequencing (NGS) aids diagnosis but misses MDM2 copy number variations critical for dedifferentiated liposarcoma (DDLPS).
Purpose of the Study:
- Develop and validate a novel screening algorithm for DDLPS using RNA NGS data.
- Improve diagnostic accuracy for DDLPS, especially in morphologically atypical cases.
Main Methods:
- Retrospective analysis of 150 patients undergoing RNA NGS.
- Developed a screening algorithm based on 12q13-15 chromosomal region fusion events and MDM2 transcript levels.
- Validated the algorithm using TCGA-SARC data.
Main Results:
- The algorithm identified significantly elevated fusion events and MDM2 transcript levels in DDLPS.
- Optimal thresholds achieved 100% sensitivity and high specificity for DDLPS detection.
- Algorithm demonstrated robustness in external validation data.
Conclusions:
- A novel RNA NGS-based algorithm effectively screens for DDLPS.
- This strategy enhances diagnostic capabilities for DDLPS and potentially other MDM2-amplified sarcomas.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016